Integer Holdings Corporation
Integer Holdings Corporation is a leading medical device outsource manufacturer. It provides innovative design and manufacturing solutions for the healthcare industry.

Join Our Programs
Our clients trust us for our expert advice and in-depth market analysis. Discover our services to gain more knowledge on investing.
Stock Market Webinar
Join our Stock Market Webinar to gain clear, actionable insights into current market trends. Learn how to analyse data, interpret signals, and make informed investment decisions with confidence. Designed for both beginners and experienced investors, this session delivers practical knowledge you can apply immediately.

Performance
Integer Holdings Corporation (NYSE: ITGR) has demonstrated strong financial performance in 2025, with first-quarter revenue increasing 7% year-over-year to $437 million, driven by organic growth and strategic acquisitions . Adjusted earnings per share (EPS) rose 14.9% to $1.31, surpassing analyst expectations . The company has raised its full-year adjusted EPS guidance to a range of $6.15 to $6.51, reflecting confidence in sustained growth.
Quality of Earnings
The company demonstrates strong adherence to General Accounting Principles, with financial reports that conform to GAAP, are decision-useful, sustainable, and offer returns exceeding the cost of capital. There have been no recent changes to accounting policies, and all required financial reports are submitted on time. Revenue quality is also robust, marked by high predictability—with a substantial portion of clients returning year after year—strong profitability with gross margins exceeding 70%, diversified income sources with no client accounting for more than 15% of revenue, and clear growth in both revenue and net income. Additionally, there are no significant financial report warning signs: earnings contain minimal accrual components, do not narrowly beat benchmarks in a suspicious pattern, and revenue is not recognized prematurely. Expenses are not misrepresented, audit opinions are unqualified, goodwill is properly assessed, and the company does not rely on aggressive accounting tactics such as related-party transactions or off-balance-sheet debt. Operating ccash flows align with net income, earnings are recurring and persistent, and there is no history of restatements or enforcement actions, reinforcing the reliability and quality of the company’s financial reporting.

Company Summary
Integer Holdings Corporation (NYSE: ITGR) is one of the world’s largest medical device contract development and manufacturing organizations (CDMOs), specializing in the design and production of complex medical technologies for the cardiac rhythm management, neuromodulation, and cardio and vascular markets.
